Trexquant Investment LP

Position in AXGN — Axogen, Inc.

CIK 1633445 STAMFORD, CT

Position in AXGN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$3,394,466

+$307,798 QoQ

Shares Held

102,459

+8.6% QoQ

Ownership

0.193%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 91.03641456582633.ToString("F0")% Shared 0.ToString("F0")% None 8.96358543417367.ToString("F0")%

Healthcare · as of Mar 31, 2026

Trexquant Investment LP holds $264,507,021 across 41 Medical Devices names. AXGN ranks #18 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EW	Edwards Lifesciences Corp	547,076	$43,809,846
2	SYK	Stryker Corp	75,199	$24,709,639
3	BSX	Boston Scientific Corp	385,491	$24,189,560
4	PODD	Insulet Corp	102,230	$21,451,943
5	DXCM	Dexcom Inc	304,067	$19,095,407
6	IRTC	iRhythm Holdings, Inc.	111,311	$13,136,924
7	HAE	Haemonetics Corp	218,010	$12,287,043
8	TMDX	TransMedics Group, Inc.	106,300	$10,567,283

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,394,466	102,459	+8.6%	Shares	Sole	2026-05-15
2025-12-31	$3,086,668	94,307	-24.0%	Shares	Sole	2026-02-17
2025-09-30	$2,213,515	124,076	-32.4%	Shares	Sole	2025-11-14
2025-03-31	$3,394,657	183,495	+827.7%	Shares	Sole	2025-05-14
2024-12-31	$325,974	19,780	-56.9%	Shares	Sole	2025-02-12
2024-09-30	$643,588	45,905	+307.6%	Shares	Sole	2024-11-12
2024-06-30	$81,536	11,262	-13.3%	Shares	Sole	2024-08-13
2023-03-31	$122,727	12,987	-48.9%	Shares	Sole	2023-05-15
2022-12-31	$253,731	25,424	+120.4%	Shares	Sole	2023-02-13
2022-09-30	$137,485	11,534	-73.3%	Shares	Sole	2022-11-14
2022-03-31	$342,992	43,198	+34.3%	Shares	Sole	2022-05-13
2020-09-30	$374,160	32,172	+169.0%	Shares	Sole	2020-11-06
2020-03-31	$124,384	11,960	—	Shares	Sole	2020-05-08
No filing history on record for this holder in this stock.